Pasithea Therapeutics Corp.
KTTA
$1.19
-$0.02-1.65%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.78M | -16.39M | -16.28M | -15.96M | -16.03M |
| Total Depreciation and Amortization | 649.20K | 649.20K | 649.20K | 648.60K | 490.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 262.60K | 710.20K | 320.20K | 313.70K | -770.90K |
| Change in Net Operating Assets | -522.50K | 108.50K | 954.90K | 1.57M | 1.81M |
| Cash from Operations | -15.39M | -14.92M | -14.36M | -13.43M | -14.50M |
| Capital Expenditure | 0.00 | 22.70K | 19.60K | -34.30K | -127.00K |
| Sale of Property, Plant, and Equipment | 54.50K | 82.00K | 109.50K | 109.50K | 55.00K |
| Cash Acquisitions | -- | -- | -- | -- | -2.25M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 594.40K | 0.00 | 323.80K | 323.80K | 828.20K |
| Cash from Investing | 648.90K | 104.70K | 452.90K | 399.00K | -1.49M |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 392.40K | 392.40K |
| Total Debt Repaid | 0.00 | -133.30K | -264.10K | -392.40K | -392.40K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | -3.73M | -3.73M | -3.73M | -3.73M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.54M | -- | -4.20K | 0.00 | 0.00 |
| Cash from Financing | 4.54M | -3.86M | -3.99M | -3.73M | -6.93M |
| Foreign Exchange rate Adjustments | -27.50K | -4.70K | -2.10K | -4.00K | 132.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.22M | -18.68M | -17.90M | -16.76M | -22.80M |
